Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma
Qianhui Xu, Yuxin Wang, Wen Huang
International Immunopharmacology (2021) Vol. 92, pp. 107333-107333
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?
Alessandro Rizzo, Antonio Cusmai, Gennaro Gadaleta‐Caldarola, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 4, pp. 333-339
Closed Access | Times Cited: 79
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
Alessandro Rizzo, Angela Dalia Ricci, Alessandro Di Federico, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 97
PD-L1, TMB, and other potential predictors of response to immunotherapy for hepatocellular carcinoma: how can they assist drug clinical trials?
Alessandro Rizzo, Angela Dalia Ricci
Expert Opinion on Investigational Drugs (2021) Vol. 31, Iss. 4, pp. 415-423
Closed Access | Times Cited: 91
Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma
Zi-An Chen, Hui Tian, Dongmei Yao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 59
Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
Xianyanling Yi, Jin Li, Xiaonan Zheng, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 376-390
Open Access | Times Cited: 30
LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3/SLC7A11 in hepatocellular carcinoma
Dong‐Yan Jin, Yongfeng Hui, Di Liu, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma via the miR-375-3P/SLC7A11 axis
Ke Zong, Cai‐Feng Lin, Kai Luo, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma
Xigang Xia, Hao Zhang, Peng Xia, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 37
Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
Qianhui Xu, Hao Xu, Rongshan Deng, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
Yuqing He, Mengyao Lu, Jing Che, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 27
Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma
Min Chen, Guangbo Wu, Shan Hua, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 21
Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4631-4631
Open Access | Times Cited: 20
Long non-coding RNA NRAV enhances proliferation and invasion of hepatocellular carcinoma cells by modulating the Wnt/β-catenin signaling pathway
Qingxian Wang, Yumei Tang, Yuansen Ge, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 10026-10037
Open Access | Times Cited: 19
LncRNA CASC19: a novel oncogene involved in human cancer
Shidong Wang, Chen Qiao, Rui Fang, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 10, pp. 2841-2851
Closed Access | Times Cited: 11
Cancer‐derived non‐coding RNAs endow tumor microenvironment with immunosuppressive properties
Tong Hu, Run Shi, Yunru Gu, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma
Xiu Chen, Liqiu Kou, Xiaolu Xie, et al.
Immunology (2024) Vol. 172, Iss. 1, pp. 21-45
Open Access | Times Cited: 4
Liquid biopsy: an emerging field with new opportunities for cancer diagnosis and prognosis
Dhahiri Saidi Mashausi, Herve Semukunzi
Asia-Pacific Journal of Oncology (2025), pp. 9-17
Open Access
Subtype cluster analysis unveiled the correlation between m6A- and cuproptosis-related lncRNAs and the prognosis, immune microenvironment, and treatment sensitivity of esophageal cancer
Mingxing Zhang, Yani Su, Pengfei Wen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
G0S2 Promotes PD-L1 Expression in Monocytes and Influences the Efficacy of PD-1 Inhibitors in Hepatocellular Carcinoma
Xueming Du, Wenwen Zhang, Sujuan Sun, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 448-448
Open Access
CASC19: An Oncogenic Long Non-coding RNA in Different Cancers
Yinxin Wu, Jie Mou, Gang Zhou, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 15, pp. 1157-1166
Closed Access | Times Cited: 3
Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
Qianhui Xu, Hao Xu, Shaohuai Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 22
An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
Xilang Chen, Mengyu Sun, Weibo Feng, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8
Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma
Yulu Wang, Fangfang Ge, Amit Sharma, et al.
Biology (2021) Vol. 10, Iss. 12, pp. 1301-1301
Open Access | Times Cited: 19
Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
Yuezhi Zhu, Jen Kit Tan, Jo Aan Goon
Biology (2023) Vol. 12, Iss. 8, pp. 1101-1101
Open Access | Times Cited: 7
Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy
Qianhui Xu, Hao Xu, Rongshan Deng, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top